MENLO PARK, Calif., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), a growth-stage medical device company focused on addressing the...
Interim results show that 250 parts per million (ppm) nitric oxide (NO) was well-tolerated with no study discontinuations or treatment-related serious adverse...
Seibersdorf Labor, a GMP Contract manufacturing of radiopharmaceuticals, a global leader in the development, production and commercialization of radiopharmaceuticals, will produce 177Lu n.c.a...